Utah Medical Products EBITDA Margin 2010-2024 | UTMD
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Utah Medical Products (UTMD) over the last 10 years. The current EBITDA margin for Utah Medical Products as of December 31, 2024 is .
Utah Medical Products EBITDA Margin Historical Data |
Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
2024-12-31 |
$0.04B |
$0.02B |
42.50% |
2024-09-30 |
$0.04B |
$0.02B |
41.86% |
2024-06-30 |
$0.05B |
$0.02B |
43.48% |
2024-03-31 |
$0.05B |
$0.02B |
44.90% |
2023-12-31 |
$0.05B |
$0.02B |
45.10% |
2023-09-30 |
$0.05B |
$0.03B |
47.17% |
2023-06-30 |
$0.05B |
$0.03B |
49.06% |
2023-03-31 |
$0.05B |
$0.03B |
50.94% |
2022-12-31 |
$0.05B |
$0.03B |
51.92% |
2022-09-30 |
$0.05B |
$0.03B |
52.94% |
2022-06-30 |
$0.05B |
$0.03B |
52.94% |
2022-03-31 |
$0.05B |
$0.03B |
52.94% |
2021-12-31 |
$0.05B |
$0.03B |
54.00% |
2021-09-30 |
$0.05B |
$0.03B |
53.06% |
2021-06-30 |
$0.05B |
$0.02B |
52.17% |
2021-03-31 |
$0.04B |
$0.02B |
50.00% |
2020-12-31 |
$0.04B |
$0.02B |
50.00% |
2020-09-30 |
$0.04B |
$0.02B |
50.00% |
2020-06-30 |
$0.04B |
$0.02B |
50.00% |
2020-03-31 |
$0.05B |
$0.02B |
51.06% |
2019-12-31 |
$0.05B |
$0.02B |
51.06% |
2019-09-30 |
$0.05B |
$0.02B |
51.11% |
2019-06-30 |
$0.04B |
$0.02B |
51.16% |
2019-03-31 |
$0.04B |
$0.02B |
52.38% |
2018-12-31 |
$0.04B |
$0.02B |
52.38% |
2018-09-30 |
$0.04B |
$0.02B |
52.38% |
2018-06-30 |
$0.04B |
$0.02B |
52.38% |
2018-03-31 |
$0.04B |
$0.02B |
52.38% |
2017-12-31 |
$0.04B |
$0.02B |
51.22% |
2017-09-30 |
$0.04B |
$0.02B |
50.00% |
2017-06-30 |
$0.04B |
$0.02B |
50.00% |
2017-03-31 |
$0.04B |
$0.02B |
48.72% |
2016-12-31 |
$0.04B |
$0.02B |
48.72% |
2016-09-30 |
$0.04B |
$0.02B |
50.00% |
2016-06-30 |
$0.04B |
$0.02B |
50.00% |
2016-03-31 |
$0.04B |
$0.02B |
50.00% |
2015-12-31 |
$0.04B |
$0.02B |
50.00% |
2015-09-30 |
$0.04B |
$0.02B |
50.00% |
2015-06-30 |
$0.04B |
$0.02B |
48.78% |
2015-03-31 |
$0.04B |
$0.02B |
48.78% |
2014-12-31 |
$0.04B |
$0.02B |
48.78% |
2014-09-30 |
$0.04B |
$0.02B |
46.34% |
2014-06-30 |
$0.04B |
$0.02B |
45.00% |
2014-03-31 |
$0.04B |
$0.02B |
45.00% |
2013-12-31 |
$0.04B |
$0.02B |
45.00% |
2013-09-30 |
$0.04B |
$0.02B |
45.00% |
2013-06-30 |
$0.04B |
$0.02B |
47.50% |
2013-03-31 |
$0.04B |
$0.02B |
45.00% |
2012-12-31 |
$0.04B |
$0.02B |
43.90% |
2012-09-30 |
$0.04B |
$0.02B |
43.90% |
2012-06-30 |
$0.04B |
$0.02B |
40.48% |
2012-03-31 |
$0.04B |
$0.02B |
40.48% |
2011-12-31 |
$0.04B |
$0.01B |
36.84% |
2011-09-30 |
$0.03B |
$0.01B |
35.29% |
2011-06-30 |
$0.03B |
$0.01B |
34.48% |
2011-03-31 |
$0.03B |
$0.01B |
32.00% |
2010-12-31 |
$0.02B |
$0.01B |
33.33% |
2010-09-30 |
$0.02B |
$0.01B |
37.50% |
2010-06-30 |
$0.03B |
$0.01B |
40.00% |
2010-03-31 |
$0.03B |
$0.01B |
40.00% |
2009-12-31 |
$0.03B |
$0.01B |
44.00% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED PRODUCTS |
$0.173B |
$0.041B |
Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques.
|